Literature DB >> 33226599

Assessment of Lung Eosinophils In Situ Using Immunohistological Staining.

Christopher D Nazaroff1,2, William E LeSuer1, Mia Y Masuda1, Grace Pyon1, Paige Lacy3, Elizabeth A Jacobsen4,5.   

Abstract

Eosinophils are rare white blood cells that are recruited from circulation to accumulate in the lung in mouse models of allergic respiratory inflammation. In hematoxylin-eosin (HE) stained lungs, eosinophils may be difficult to detect despite their bright eosin staining in the secondary granules. For this reason, antibody-mediated detection of eosinophils is preferable for specific and clearer identification of these cells. Moreover, eosinophils may degranulate, releasing their granule proteins into surrounding tissue, and remnants of cytolysed cells cannot be detected by HE staining. The methods here demonstrate the use of eosinophil-specific anti-mouse antibodies to detect eosinophil granule proteins in formalin-fixed cells both in situ in paraffin-embedded lungs, as well as in cytospin preparations from the lung. These antibody staining techniques enable either colorimetric or fluorescence imaging of eosinophils or their granule proteins with the potential for additional antibodies to be added for detection of multiple molecules.

Entities:  

Keywords:  Eosinophil peroxidase; Eosinophils; Fluorescence; Formalin-fixed; Granule proteins; Immunohistochemistry; Lung; Major basic protein; Staining

Year:  2021        PMID: 33226599      PMCID: PMC7869952          DOI: 10.1007/978-1-0716-1001-5_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  61 in total

Review 1.  Control of eosinophil toxicity in the lung.

Authors:  G M Walsh; M Al-Rabia; M G Blaylock; D W Sexton; C J A Duncan; A Lawrie
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-08

Review 2.  An Introduction to the Performance of Immunohistochemistry.

Authors:  Shino Magaki; Seyed A Hojat; Bowen Wei; Alexandra So; William H Yong
Journal:  Methods Mol Biol       Date:  2019

Review 3.  Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades.

Authors:  Shan-Rong Shi; Yan Shi; Clive R Taylor
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

4.  Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation.

Authors:  Elizabeth A Jacobsen; Sergei I Ochkur; Alfred D Doyle; William E LeSuer; Wen Li; Cheryl A Protheroe; Dana Colbert; Katie R Zellner; HuaHao H Shen; Charles G Irvin; James J Lee; Nancy A Lee
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

Review 5.  Eosinophilic Endotype of Asthma.

Authors:  Fernando Aleman; Hui Fang Lim; Parameswaran Nair
Journal:  Immunol Allergy Clin North Am       Date:  2016-08       Impact factor: 3.479

6.  Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse.

Authors:  M T Garba; P J Marie
Journal:  Calcif Tissue Int       Date:  1986-05       Impact factor: 4.333

7.  Double immunofluorescent staining of rat macrophages in formalin-fixed paraffin-embedded tissue using two monoclonal mouse antibodies.

Authors:  Raymond A Isidro; Angel A Isidro; Myrella L Cruz; Siomara Hernandez; Caroline B Appleyard
Journal:  Histochem Cell Biol       Date:  2015-09-24       Impact factor: 4.304

Review 8.  Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis.

Authors:  Edward C Stack; Chichung Wang; Kristin A Roman; Clifford C Hoyt
Journal:  Methods       Date:  2014-09-19       Impact factor: 3.608

Review 9.  Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips.

Authors:  So-Woon Kim; Jin Roh; Chan-Sik Park
Journal:  J Pathol Transl Med       Date:  2016-10-13

Review 10.  Eosinophils: changing perspectives in health and disease.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Paul S Foster
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.